Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agentMasayoshi Arai, Motomasa Kobayashi, Mari Sobou et al.|Bioorganic & Medicinal Chemistry|2008Cited by 75
Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting databaseNaoto Okada, Keisuke Ishizawa, Shunsuke Ishida et al.|Cancer Medicine|2018Cited by 23
Non‐recovery of vancomycin‐associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real‐world databasesMasayuki Chuma, Keisuke Ishizawa, Hirofumi Hamano et al.|Basic & Clinical Pharmacology & Toxicology|2022Cited by 5
Development and pharmacist‐mediated use of tools for monitoring atypical antipsychotic‐induced side effects related to blood glucose levelsShunsuke Ishida, Keisuke Ishizawa, Kenshi Takechi et al.|Pharmacoepidemiology and Drug Safety|2018Cited by 3
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective StudyHirofumi Hamano, Keisuke Ishizawa, Chisato Mitsuhashi et al.|Biological and Pharmaceutical Bulletin|2021Cited by 3